Age, host response, and mortality in COVID-19
- PMID: 37419522
- PMCID: PMC10327539
- DOI: 10.1183/13993003.00796-2023
Age, host response, and mortality in COVID-19
Abstract
Increased age is a strong risk factor for mortality in patients with COVID-19. Understanding the dynamic changes in plasma biomarkers associated with age is crucial for unravelling the intricate interplay between ageing, immune response and outcomes.
Conflict of interest statement
Conflict of interest: The authors have no potential conflicts of interest to disclose.
Figures
Comment on
-
Age-related changes in plasma biomarkers and their association with mortality in COVID-19.Eur Respir J. 2023 Jul 7;62(1):2300011. doi: 10.1183/13993003.00011-2023. Print 2023 Jul. Eur Respir J. 2023. PMID: 37080568 Free PMC article.
Similar articles
-
SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers.J Med Virol. 2022 Jan;94(1):222-228. doi: 10.1002/jmv.27300. Epub 2021 Sep 1. J Med Virol. 2022. PMID: 34449894 Free PMC article.
-
Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.mSphere. 2021 Jan 20;6(1):e01324-20. doi: 10.1128/mSphere.01324-20. mSphere. 2021. PMID: 33472985 Free PMC article.
-
Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities.Cardiovasc Res. 2020 Dec 1;116(14):2197-2206. doi: 10.1093/cvr/cvaa284. Cardiovasc Res. 2020. PMID: 33063089 Free PMC article. Review.
-
Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations.Sci Rep. 2021 Nov 1;11(1):21352. doi: 10.1038/s41598-021-00459-4. Sci Rep. 2021. PMID: 34725366 Free PMC article.
-
Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis.Sci Rep. 2021 Mar 18;11(1):6283. doi: 10.1038/s41598-021-85359-3. Sci Rep. 2021. PMID: 33737527 Free PMC article.
Cited by
-
COVID-19 Clinical Features and Outcome in Italian Patients Treated with Biological Drugs Targeting Type 2 Inflammation.Life (Basel). 2024 Mar 13;14(3):378. doi: 10.3390/life14030378. Life (Basel). 2024. PMID: 38541703 Free PMC article.
-
Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes.Open Med (Wars). 2023 Oct 27;18(1):20230822. doi: 10.1515/med-2023-0822. eCollection 2023. Open Med (Wars). 2023. PMID: 37900963 Free PMC article.
-
Impact of SARS-CoV-2 infection on patients with myasthenia gravis: a retrospective study in a Chinese population.Front Neurol. 2024 Dec 11;15:1482932. doi: 10.3389/fneur.2024.1482932. eCollection 2024. Front Neurol. 2024. PMID: 39722700 Free PMC article.
-
Predictors of SARS-CoV-2 Infection and Severe and Lethal COVID-19 after Three Years of Follow-Up: A Population-Wide Study.Viruses. 2023 Aug 24;15(9):1794. doi: 10.3390/v15091794. Viruses. 2023. PMID: 37766201 Free PMC article.
-
Nursing workload and severity of COVID-19 patients in the Intensive Care Unit.Rev Esc Enferm USP. 2024 Aug 23;58:e20240107. doi: 10.1590/1980-220X-REEUSP-2024-0107en. eCollection 2024. Rev Esc Enferm USP. 2024. PMID: 39190876 Free PMC article.
References
-
- World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Date last assessed: 11 May 2023. https://covid19.who.int/
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical